2014
DOI: 10.1016/j.bcp.2014.04.007
|View full text |Cite
|
Sign up to set email alerts
|

The phenotype of a flavin-containing monooyxgenase knockout mouse implicates the drug-metabolizing enzyme FMO1 as a novel regulator of energy balance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
45
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 40 publications
(49 citation statements)
references
References 39 publications
3
45
0
Order By: Relevance
“…Thus the down-regulation in this study was surprising, but may indicate a compensatory mechanism reflecting increased enzymatic activities. Interestingly, loss of Fmo1 in mice was recently shown to result in a lean phenotype in mice, thus being involved in the regulation of energy homeostasis [29]. We also observed a lower body weight in exposed animals.…”
Section: Discussionsupporting
confidence: 70%
“…Thus the down-regulation in this study was surprising, but may indicate a compensatory mechanism reflecting increased enzymatic activities. Interestingly, loss of Fmo1 in mice was recently shown to result in a lean phenotype in mice, thus being involved in the regulation of energy homeostasis [29]. We also observed a lower body weight in exposed animals.…”
Section: Discussionsupporting
confidence: 70%
“…The former study suggested that mFMO3's effects were peroxisome proliferator-activated receptor ␣ (PPAR␣)-and KLF15-mediated, whereas the latter study concluded that mFMO3 affected cholesterol balance through TMAO production, but that mFMO3's effects on lipids and inflammation were mediated by another substrate. Two other reports examining mFmo1 and mFmo5 knock-out mice, respectively, found that both were capable of altering metabolism and energy balance sufficiently to cause gross alterations in body size (58,59). A recent review discusses these mFMO-related effects on carbohydrate and lipid metabolism and energy balance (60).…”
Section: Diabetes and Metabolic Disordersmentioning
confidence: 99%
“…In mammals, there is relatively limited information on the specific functions of each FMO beyond tissue-specific expression patterns and the role of FMO3 in a single human disease, fish-odor syndrome (23). Mammalian FMOs also have a major role in regulating cholesterol and fat metabolism (24, 25). Abundance of FMO proteins is increased in the tissues, particularly liver, of several long-lived mouse models including Snell dwarf mice, Ames dwarf mice, growth-hormone receptor knockout mice, Little mice, dietary restricted mice, and rapamycin-fed mice (26).…”
mentioning
confidence: 99%